Orchard therapeutics appoints robin kenselaar to chief commercial officer and announces multiple business updates pertaining to its approved hsc gene therapy for mld

First u.s. patients being treated with lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following food and drug administration approval last year

HSC Ratings Summary

HSC Quant Ranking